Ignite Creation Date:
2024-05-06 @ 7:18 PM
Last Modification Date:
2025-12-17 @ 8:15 AM
Study NCT ID:
NCT05965141
Status:
None
Last Update Posted:
2023-07-28 00:00:00
First Post:
2023-04-23 00:00:00
Brief Title:
Aribulin Combined With Carboplatin and Bevacizumab in the Treatment of Ovarian Cancer
Sponsor:
Organization:
Second Affiliated Hospital of Guangzhou Medical University
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
38
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE1 |
| PHASE2 |
Observational Models:
Time Perspective List:
Who Masked List: